Stock Price Quote

HIKAL LTD.

NSE : HIKALBSE : 524735ISIN CODE : INE475B01022Industry : Pharmaceuticals & DrugsHouse : Kalyani
BSE298.70-4.45 (-1.47 %)
PREV CLOSE ( ) 303.15
OPEN PRICE ( ) 301.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18341
TODAY'S LOW / HIGH ( )296.85 303.95
52 WK LOW / HIGH ( )258.6 328.6
NSE298.55-4.45 (-1.47 %)
PREV CLOSE( ) 303.00
OPEN PRICE ( ) 300.00
BID PRICE (QTY) 298.55 (4)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 239703
TODAY'S LOW / HIGH( ) 297.00 303.85
52 WK LOW / HIGH ( )250.1 329
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988
Management Info
Jai Hiremath - Chairman Sameer Hiremath - Managing Director
Registered Office

Address 717 / 718,Maker Chambers V,Nariman Point,
Mumbai,
Maharashtra-400021

Phone 022-39267100 / 62770477

Email info@hikal.com

Website www.hikal.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Road,Vikhroli West,Mumbai
Listing : BSE, NSE, MCX

NEWS

23Feb Hikal informs about disclosure
Hikal has informed that the Hon’ble High Court of Bombay, vide its order..
06Jan Hikal informs about disclosure
In continuation of its earlier disclosures dated 15th December 2023 and..
29Dec HIKAL informs about disclosure
In continuation of earlier disclosure dated 15th December 2023, HIKAL ha..
31Aug Hikal informs about press release
Hikal has informed that it enclosed the copies of Public Notice publishe..
22May Hikal informs about board meeting
Pursuant to the provisions of Regulations 29 and 33 of the Securities an..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit162.700000000001783.800000000005
Gross Profit 217.4 1053.6
Operating Profit 649.52624.7
Net Sales 4475.720230.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
peergroup  551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
peergroup  26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
peergroup  555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
peergroup  1595.25 (1.05%)
M.Cap ( in Cr)16688.90

Shareholding Pattern

PROMOTERS 68.85%
MUTUAL FUNDS/UTI 3.03%
NON-INSTITUTION 21.07%
FI/BANKS/INSURANCE 0.12%
GOVERNMENT 0%
FII 0%

About Hikal Ltd.

Hikal Ltd. was incorporated in the year 1988. Its today's share price is 298.7. Its current market capitalisation stands at Rs 3682.99 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20230.3 Cr and Total Income of Rs.20284.4 Cr. The company's management includes V Ramachandra Kaundinya, Berjis M Desai, Rajasekhar Reddy, Shrikrishna K Adivarekar, Shivani Bhasin Sachdeva, Amit Kalyani, Sugandha Hiremath, Prakash Mehta, Sameer Hiremath, Baba Kalyani, Jai Hiremath.

It is listed on the BSE with a BSE Code of 524735 , NSE with an NSE Symbol of HIKAL and ISIN of INE475B01022. It's Registered office is at 717 / 718,Maker Chambers V,Nariman PointMumbai-400021, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co, BSR & Co LLP, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.